Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006)
American Journal of Pathology - United States
doi 10.2353/ajpath.2006.050711
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2006
Authors
Publisher
Elsevier BV